nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—Dinoprostone—SLC51A—osteoporosis	0.0111	0.841	CrCbGaD
Bimatoprost—Dinoprostone—CYP19A1—osteoporosis	0.00209	0.158	CrCbGaD
Bimatoprost—Chest pain—Alendronate—osteoporosis	0.00117	0.00172	CcSEcCtD
Bimatoprost—Dyspepsia—Etidronic acid—osteoporosis	0.00116	0.00171	CcSEcCtD
Bimatoprost—Hypertension—Ibandronate—osteoporosis	0.00116	0.0017	CcSEcCtD
Bimatoprost—Chest pain—Raloxifene—osteoporosis	0.00116	0.00169	CcSEcCtD
Bimatoprost—Angiopathy—Risedronate—osteoporosis	0.00115	0.00169	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00115	0.00168	CcSEcCtD
Bimatoprost—Mediastinal disorder—Risedronate—osteoporosis	0.00115	0.00168	CcSEcCtD
Bimatoprost—Chest pain—Ibandronate—osteoporosis	0.00114	0.00168	CcSEcCtD
Bimatoprost—Anxiety—Ibandronate—osteoporosis	0.00114	0.00167	CcSEcCtD
Bimatoprost—Infection—Estropipate—osteoporosis	0.00114	0.00167	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00114	0.00167	CcSEcCtD
Bimatoprost—Liver function test abnormal—Estradiol—osteoporosis	0.00114	0.00167	CcSEcCtD
Bimatoprost—Hypertension—Calcitriol—osteoporosis	0.00114	0.00166	CcSEcCtD
Bimatoprost—Eye disorder—Pamidronate—osteoporosis	0.00113	0.00166	CcSEcCtD
Bimatoprost—Dry skin—Estradiol—osteoporosis	0.00113	0.00165	CcSEcCtD
Bimatoprost—Nervous system disorder—Estropipate—osteoporosis	0.00112	0.00164	CcSEcCtD
Bimatoprost—Chest pain—Calcitriol—osteoporosis	0.00112	0.00164	CcSEcCtD
Bimatoprost—Infection—Alendronate—osteoporosis	0.00112	0.00164	CcSEcCtD
Bimatoprost—Dry mouth—Ibandronate—osteoporosis	0.00112	0.00164	CcSEcCtD
Bimatoprost—Anxiety—Calcitriol—osteoporosis	0.00112	0.00164	CcSEcCtD
Bimatoprost—Sinusitis—Conjugated Estrogens—osteoporosis	0.00111	0.00163	CcSEcCtD
Bimatoprost—Skin disorder—Estropipate—osteoporosis	0.00111	0.00163	CcSEcCtD
Bimatoprost—Infection—Raloxifene—osteoporosis	0.0011	0.00161	CcSEcCtD
Bimatoprost—Nasopharyngitis—Estradiol—osteoporosis	0.0011	0.00161	CcSEcCtD
Bimatoprost—Angiopathy—Pamidronate—osteoporosis	0.0011	0.00161	CcSEcCtD
Bimatoprost—Dry mouth—Calcitriol—osteoporosis	0.00109	0.00161	CcSEcCtD
Bimatoprost—Mediastinal disorder—Pamidronate—osteoporosis	0.00109	0.0016	CcSEcCtD
Bimatoprost—Infection—Ibandronate—osteoporosis	0.00109	0.0016	CcSEcCtD
Bimatoprost—Oedema peripheral—Zoledronate—osteoporosis	0.00109	0.0016	CcSEcCtD
Bimatoprost—Nervous system disorder—Raloxifene—osteoporosis	0.00109	0.00159	CcSEcCtD
Bimatoprost—Connective tissue disorder—Zoledronate—osteoporosis	0.00108	0.00159	CcSEcCtD
Bimatoprost—Skin disorder—Raloxifene—osteoporosis	0.00108	0.00158	CcSEcCtD
Bimatoprost—Nervous system disorder—Ibandronate—osteoporosis	0.00107	0.00158	CcSEcCtD
Bimatoprost—Rhinitis—Conjugated Estrogens—osteoporosis	0.00107	0.00156	CcSEcCtD
Bimatoprost—Skin disorder—Ibandronate—osteoporosis	0.00106	0.00156	CcSEcCtD
Bimatoprost—Asthma—Estradiol—osteoporosis	0.00106	0.00156	CcSEcCtD
Bimatoprost—Nausea—Ergocalciferol—osteoporosis	0.00106	0.00155	CcSEcCtD
Bimatoprost—Pharyngitis—Conjugated Estrogens—osteoporosis	0.00106	0.00155	CcSEcCtD
Bimatoprost—Erythema—Pamidronate—osteoporosis	0.00105	0.00154	CcSEcCtD
Bimatoprost—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00105	0.00154	CcSEcCtD
Bimatoprost—Skin disorder—Calcitriol—osteoporosis	0.00104	0.00153	CcSEcCtD
Bimatoprost—Insomnia—Estropipate—osteoporosis	0.00103	0.00152	CcSEcCtD
Bimatoprost—Tension—Pamidronate—osteoporosis	0.00103	0.00151	CcSEcCtD
Bimatoprost—Eye disorder—Zoledronate—osteoporosis	0.00103	0.00151	CcSEcCtD
Bimatoprost—Visual impairment—Conjugated Estrogens—osteoporosis	0.00102	0.0015	CcSEcCtD
Bimatoprost—Bronchitis—Estradiol—osteoporosis	0.00102	0.0015	CcSEcCtD
Bimatoprost—Nervousness—Pamidronate—osteoporosis	0.00102	0.0015	CcSEcCtD
Bimatoprost—Somnolence—Estropipate—osteoporosis	0.00102	0.00149	CcSEcCtD
Bimatoprost—Dyspepsia—Estropipate—osteoporosis	0.00101	0.00148	CcSEcCtD
Bimatoprost—Angiopathy—Zoledronate—osteoporosis	0.001	0.00147	CcSEcCtD
Bimatoprost—Insomnia—Raloxifene—osteoporosis	0.001	0.00147	CcSEcCtD
Bimatoprost—Mediastinal disorder—Zoledronate—osteoporosis	0.000995	0.00146	CcSEcCtD
Bimatoprost—Vertigo—Risedronate—osteoporosis	0.000994	0.00146	CcSEcCtD
Bimatoprost—Eye disorder—Conjugated Estrogens—osteoporosis	0.000994	0.00146	CcSEcCtD
Bimatoprost—Insomnia—Ibandronate—osteoporosis	0.000991	0.00145	CcSEcCtD
Bimatoprost—Dyspepsia—Alendronate—osteoporosis	0.000991	0.00145	CcSEcCtD
Bimatoprost—Cough—Ethinyl Estradiol—osteoporosis	0.000991	0.00145	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Estradiol—osteoporosis	0.000988	0.00145	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Estropipate—osteoporosis	0.000987	0.00145	CcSEcCtD
Bimatoprost—Pain—Estropipate—osteoporosis	0.000978	0.00143	CcSEcCtD
Bimatoprost—Dyspepsia—Raloxifene—osteoporosis	0.000975	0.00143	CcSEcCtD
Bimatoprost—Insomnia—Calcitriol—osteoporosis	0.000971	0.00142	CcSEcCtD
Bimatoprost—Cough—Risedronate—osteoporosis	0.000966	0.00142	CcSEcCtD
Bimatoprost—Dyspepsia—Ibandronate—osteoporosis	0.000965	0.00142	CcSEcCtD
Bimatoprost—Angiopathy—Conjugated Estrogens—osteoporosis	0.000965	0.00141	CcSEcCtD
Bimatoprost—Anxiety—Ethinyl Estradiol—osteoporosis	0.000963	0.00141	CcSEcCtD
Bimatoprost—Pain—Alendronate—osteoporosis	0.000963	0.00141	CcSEcCtD
Bimatoprost—Erythema—Zoledronate—osteoporosis	0.000961	0.00141	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00096	0.00141	CcSEcCtD
Bimatoprost—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000958	0.00141	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000956	0.0014	CcSEcCtD
Bimatoprost—Hypertension—Risedronate—osteoporosis	0.000956	0.0014	CcSEcCtD
Bimatoprost—Somnolence—Calcitriol—osteoporosis	0.000954	0.0014	CcSEcCtD
Bimatoprost—Pain—Raloxifene—osteoporosis	0.000947	0.00139	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000946	0.00139	CcSEcCtD
Bimatoprost—Depression—Estradiol—osteoporosis	0.000945	0.00139	CcSEcCtD
Bimatoprost—Chest pain—Risedronate—osteoporosis	0.000942	0.00138	CcSEcCtD
Bimatoprost—Anxiety—Risedronate—osteoporosis	0.000939	0.00138	CcSEcCtD
Bimatoprost—Pain—Ibandronate—osteoporosis	0.000937	0.00137	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000936	0.00137	CcSEcCtD
Bimatoprost—Pruritus—Etidronic acid—osteoporosis	0.000935	0.00137	CcSEcCtD
Bimatoprost—Erythema—Conjugated Estrogens—osteoporosis	0.000925	0.00136	CcSEcCtD
Bimatoprost—Dry mouth—Risedronate—osteoporosis	0.000922	0.00135	CcSEcCtD
Bimatoprost—Infection—Ethinyl Estradiol—osteoporosis	0.00092	0.00135	CcSEcCtD
Bimatoprost—Cough—Pamidronate—osteoporosis	0.000918	0.00135	CcSEcCtD
Bimatoprost—Pain—Calcitriol—osteoporosis	0.000918	0.00135	CcSEcCtD
Bimatoprost—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000909	0.00133	CcSEcCtD
Bimatoprost—Hypertension—Pamidronate—osteoporosis	0.000908	0.00133	CcSEcCtD
Bimatoprost—Tension—Conjugated Estrogens—osteoporosis	0.000908	0.00133	CcSEcCtD
Bimatoprost—Vision blurred—Zoledronate—osteoporosis	0.000906	0.00133	CcSEcCtD
Bimatoprost—Skin disorder—Ethinyl Estradiol—osteoporosis	0.0009	0.00132	CcSEcCtD
Bimatoprost—Nervousness—Conjugated Estrogens—osteoporosis	0.000899	0.00132	CcSEcCtD
Bimatoprost—Infection—Risedronate—osteoporosis	0.000897	0.00132	CcSEcCtD
Bimatoprost—Anxiety—Pamidronate—osteoporosis	0.000893	0.00131	CcSEcCtD
Bimatoprost—Sinusitis—Estradiol—osteoporosis	0.000889	0.0013	CcSEcCtD
Bimatoprost—Nervous system disorder—Risedronate—osteoporosis	0.000886	0.0013	CcSEcCtD
Bimatoprost—Skin disorder—Risedronate—osteoporosis	0.000877	0.00129	CcSEcCtD
Bimatoprost—Vision blurred—Conjugated Estrogens—osteoporosis	0.000872	0.00128	CcSEcCtD
Bimatoprost—Vertigo—Zoledronate—osteoporosis	0.000864	0.00127	CcSEcCtD
Bimatoprost—Infection—Pamidronate—osteoporosis	0.000853	0.00125	CcSEcCtD
Bimatoprost—Rhinitis—Estradiol—osteoporosis	0.000853	0.00125	CcSEcCtD
Bimatoprost—Palpitations—Zoledronate—osteoporosis	0.000849	0.00125	CcSEcCtD
Bimatoprost—Pharyngitis—Estradiol—osteoporosis	0.000844	0.00124	CcSEcCtD
Bimatoprost—Nervous system disorder—Pamidronate—osteoporosis	0.000842	0.00124	CcSEcCtD
Bimatoprost—Cough—Zoledronate—osteoporosis	0.000839	0.00123	CcSEcCtD
Bimatoprost—Oedema peripheral—Estradiol—osteoporosis	0.000838	0.00123	CcSEcCtD
Bimatoprost—Connective tissue disorder—Estradiol—osteoporosis	0.000836	0.00123	CcSEcCtD
Bimatoprost—Rash—Etidronic acid—osteoporosis	0.000833	0.00122	CcSEcCtD
Bimatoprost—Dermatitis—Etidronic acid—osteoporosis	0.000832	0.00122	CcSEcCtD
Bimatoprost—Vertigo—Conjugated Estrogens—osteoporosis	0.000831	0.00122	CcSEcCtD
Bimatoprost—Hypertension—Zoledronate—osteoporosis	0.00083	0.00122	CcSEcCtD
Bimatoprost—Headache—Etidronic acid—osteoporosis	0.000828	0.00121	CcSEcCtD
Bimatoprost—Asthenia—Estropipate—osteoporosis	0.00082	0.0012	CcSEcCtD
Bimatoprost—Visual impairment—Estradiol—osteoporosis	0.00082	0.0012	CcSEcCtD
Bimatoprost—Chest pain—Zoledronate—osteoporosis	0.000818	0.0012	CcSEcCtD
Bimatoprost—Palpitations—Conjugated Estrogens—osteoporosis	0.000818	0.0012	CcSEcCtD
Bimatoprost—Insomnia—Risedronate—osteoporosis	0.000817	0.0012	CcSEcCtD
Bimatoprost—Anxiety—Zoledronate—osteoporosis	0.000815	0.0012	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000813	0.00119	CcSEcCtD
Bimatoprost—Pruritus—Estropipate—osteoporosis	0.000809	0.00119	CcSEcCtD
Bimatoprost—Asthenia—Alendronate—osteoporosis	0.000808	0.00118	CcSEcCtD
Bimatoprost—Cough—Conjugated Estrogens—osteoporosis	0.000808	0.00118	CcSEcCtD
Bimatoprost—Dyspnoea—Risedronate—osteoporosis	0.000805	0.00118	CcSEcCtD
Bimatoprost—Dry mouth—Zoledronate—osteoporosis	0.0008	0.00117	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0008	0.00117	CcSEcCtD
Bimatoprost—Pruritus—Alendronate—osteoporosis	0.000797	0.00117	CcSEcCtD
Bimatoprost—Dyspepsia—Risedronate—osteoporosis	0.000795	0.00117	CcSEcCtD
Bimatoprost—Eye disorder—Estradiol—osteoporosis	0.000795	0.00117	CcSEcCtD
Bimatoprost—AKR1C3—Disease—ANTXR2—osteoporosis	0.000793	0.0026	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—PTHLH—osteoporosis	0.000788	0.00258	CbGpPWpGaD
Bimatoprost—Chest pain—Conjugated Estrogens—osteoporosis	0.000788	0.00116	CcSEcCtD
Bimatoprost—Asthenia—Ibandronate—osteoporosis	0.000786	0.00115	CcSEcCtD
Bimatoprost—Anxiety—Conjugated Estrogens—osteoporosis	0.000785	0.00115	CcSEcCtD
Bimatoprost—Nausea—Etidronic acid—osteoporosis	0.000785	0.00115	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000782	0.00115	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Risedronate—osteoporosis	0.00078	0.00114	CcSEcCtD
Bimatoprost—Infection—Zoledronate—osteoporosis	0.000779	0.00114	CcSEcCtD
Bimatoprost—Insomnia—Pamidronate—osteoporosis	0.000777	0.00114	CcSEcCtD
Bimatoprost—Pruritus—Ibandronate—osteoporosis	0.000776	0.00114	CcSEcCtD
Bimatoprost—Pain—Risedronate—osteoporosis	0.000773	0.00113	CcSEcCtD
Bimatoprost—Angiopathy—Estradiol—osteoporosis	0.000772	0.00113	CcSEcCtD
Bimatoprost—Asthenia—Calcitriol—osteoporosis	0.00077	0.00113	CcSEcCtD
Bimatoprost—Nervous system disorder—Zoledronate—osteoporosis	0.000769	0.00113	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000768	0.00252	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Estradiol—osteoporosis	0.000767	0.00112	CcSEcCtD
Bimatoprost—Dyspnoea—Pamidronate—osteoporosis	0.000766	0.00112	CcSEcCtD
Bimatoprost—Somnolence—Pamidronate—osteoporosis	0.000763	0.00112	CcSEcCtD
Bimatoprost—Skin disorder—Zoledronate—osteoporosis	0.000762	0.00112	CcSEcCtD
Bimatoprost—Pruritus—Calcitriol—osteoporosis	0.000759	0.00111	CcSEcCtD
Bimatoprost—Dyspepsia—Pamidronate—osteoporosis	0.000756	0.00111	CcSEcCtD
Bimatoprost—Dizziness—Estropipate—osteoporosis	0.000756	0.00111	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—MGLL—osteoporosis	0.000754	0.00247	CbGpPWpGaD
Bimatoprost—Infection—Conjugated Estrogens—osteoporosis	0.00075	0.0011	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—CALCR—osteoporosis	0.00075	0.00246	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTH1R—osteoporosis	0.00075	0.00246	CbGpPWpGaD
Bimatoprost—Dizziness—Alendronate—osteoporosis	0.000745	0.00109	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000741	0.00109	CcSEcCtD
Bimatoprost—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000741	0.00109	CcSEcCtD
Bimatoprost—Erythema—Estradiol—osteoporosis	0.000741	0.00109	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—MGLL—osteoporosis	0.000738	0.00242	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PTH—osteoporosis	0.000734	0.00241	CbGpPWpGaD
Bimatoprost—Pain—Pamidronate—osteoporosis	0.000734	0.00108	CcSEcCtD
Bimatoprost—Skin disorder—Conjugated Estrogens—osteoporosis	0.000734	0.00108	CcSEcCtD
Bimatoprost—Dizziness—Raloxifene—osteoporosis	0.000732	0.00107	CcSEcCtD
Bimatoprost—Tension—Estradiol—osteoporosis	0.000727	0.00107	CcSEcCtD
Bimatoprost—Dizziness—Ibandronate—osteoporosis	0.000725	0.00106	CcSEcCtD
Bimatoprost—Rash—Estropipate—osteoporosis	0.000721	0.00106	CcSEcCtD
Bimatoprost—Dermatitis—Estropipate—osteoporosis	0.00072	0.00106	CcSEcCtD
Bimatoprost—Nervousness—Estradiol—osteoporosis	0.000719	0.00106	CcSEcCtD
Bimatoprost—Headache—Estropipate—osteoporosis	0.000716	0.00105	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CNR2—osteoporosis	0.000716	0.00235	CbGpPWpGaD
Bimatoprost—Rash—Alendronate—osteoporosis	0.00071	0.00104	CcSEcCtD
Bimatoprost—Insomnia—Zoledronate—osteoporosis	0.000709	0.00104	CcSEcCtD
Bimatoprost—Dermatitis—Alendronate—osteoporosis	0.000709	0.00104	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—CALCA—osteoporosis	0.000709	0.00232	CbGpPWpGaD
Bimatoprost—Headache—Alendronate—osteoporosis	0.000705	0.00103	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—FDPS—osteoporosis	0.0007	0.0023	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PKM—osteoporosis	0.0007	0.0023	CbGpPWpGaD
Bimatoprost—Dyspnoea—Zoledronate—osteoporosis	0.000699	0.00103	CcSEcCtD
Bimatoprost—Rash—Raloxifene—osteoporosis	0.000698	0.00102	CcSEcCtD
Bimatoprost—Dermatitis—Raloxifene—osteoporosis	0.000697	0.00102	CcSEcCtD
Bimatoprost—Somnolence—Zoledronate—osteoporosis	0.000697	0.00102	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CALCA—osteoporosis	0.000694	0.00227	CbGpPWpGaD
Bimatoprost—Headache—Raloxifene—osteoporosis	0.000694	0.00102	CcSEcCtD
Bimatoprost—Rash—Ibandronate—osteoporosis	0.000691	0.00101	CcSEcCtD
Bimatoprost—Dermatitis—Ibandronate—osteoporosis	0.000691	0.00101	CcSEcCtD
Bimatoprost—Dyspepsia—Zoledronate—osteoporosis	0.00069	0.00101	CcSEcCtD
Bimatoprost—Headache—Ibandronate—osteoporosis	0.000687	0.00101	CcSEcCtD
Bimatoprost—Insomnia—Conjugated Estrogens—osteoporosis	0.000683	0.001	CcSEcCtD
Bimatoprost—Nausea—Estropipate—osteoporosis	0.000679	0.000996	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000677	0.000993	CcSEcCtD
Bimatoprost—Rash—Calcitriol—osteoporosis	0.000677	0.000992	CcSEcCtD
Bimatoprost—Dermatitis—Calcitriol—osteoporosis	0.000676	0.000991	CcSEcCtD
Bimatoprost—AKR1C3—Disease—GSN—osteoporosis	0.000674	0.00221	CbGpPWpGaD
Bimatoprost—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000673	0.000988	CcSEcCtD
Bimatoprost—Headache—Calcitriol—osteoporosis	0.000672	0.000986	CcSEcCtD
Bimatoprost—Somnolence—Conjugated Estrogens—osteoporosis	0.000671	0.000985	CcSEcCtD
Bimatoprost—Pain—Zoledronate—osteoporosis	0.000671	0.000984	CcSEcCtD
Bimatoprost—Nausea—Alendronate—osteoporosis	0.000669	0.000981	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—PTH—osteoporosis	0.000667	0.00219	CbGpPWpGaD
Bimatoprost—Vertigo—Estradiol—osteoporosis	0.000665	0.000976	CcSEcCtD
Bimatoprost—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000665	0.000975	CcSEcCtD
Bimatoprost—Asthenia—Ethinyl Estradiol—osteoporosis	0.000665	0.000975	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GPD2—osteoporosis	0.000664	0.00218	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PGLS—osteoporosis	0.000664	0.00218	CbGpPWpGaD
Bimatoprost—Nausea—Raloxifene—osteoporosis	0.000658	0.000965	CcSEcCtD
Bimatoprost—Pruritus—Ethinyl Estradiol—osteoporosis	0.000656	0.000962	CcSEcCtD
Bimatoprost—Palpitations—Estradiol—osteoporosis	0.000655	0.00096	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000652	0.000956	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000651	0.00214	CbGpPWpGaD
Bimatoprost—Nausea—Ibandronate—osteoporosis	0.000651	0.000955	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CNR2—osteoporosis	0.00065	0.00213	CbGpPWpGaD
Bimatoprost—Asthenia—Risedronate—osteoporosis	0.000648	0.000951	CcSEcCtD
Bimatoprost—Cough—Estradiol—osteoporosis	0.000646	0.000948	CcSEcCtD
Bimatoprost—Pain—Conjugated Estrogens—osteoporosis	0.000646	0.000947	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000642	0.0021	CbGpPWpGaD
Bimatoprost—Hypertension—Estradiol—osteoporosis	0.000639	0.000938	CcSEcCtD
Bimatoprost—Pruritus—Risedronate—osteoporosis	0.000639	0.000937	CcSEcCtD
Bimatoprost—Nausea—Calcitriol—osteoporosis	0.000637	0.000935	CcSEcCtD
Bimatoprost—Chest pain—Estradiol—osteoporosis	0.000631	0.000925	CcSEcCtD
Bimatoprost—Anxiety—Estradiol—osteoporosis	0.000628	0.000922	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000628	0.00206	CbGpPWpGaD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000626	0.000919	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—SOST—osteoporosis	0.00062	0.00203	CbGpPWpGaD
Bimatoprost—Dry mouth—Estradiol—osteoporosis	0.000617	0.000905	CcSEcCtD
Bimatoprost—Asthenia—Pamidronate—osteoporosis	0.000616	0.000904	CcSEcCtD
Bimatoprost—Dizziness—Ethinyl Estradiol—osteoporosis	0.000613	0.000899	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—WNT1—osteoporosis	0.000611	0.002	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—PTHLH—osteoporosis	0.000609	0.00199	CbGpPWpGaD
Bimatoprost—Pruritus—Pamidronate—osteoporosis	0.000608	0.000891	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—PNP—osteoporosis	0.000607	0.00199	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ATIC—osteoporosis	0.000607	0.00199	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SOST—osteoporosis	0.000607	0.00199	CbGpPWpGaD
Bimatoprost—Infection—Estradiol—osteoporosis	0.000601	0.000881	CcSEcCtD
Bimatoprost—Dizziness—Risedronate—osteoporosis	0.000597	0.000876	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—MGLL—osteoporosis	0.000596	0.00195	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Estradiol—osteoporosis	0.000593	0.00087	CcSEcCtD
Bimatoprost—Skin disorder—Estradiol—osteoporosis	0.000587	0.000861	CcSEcCtD
Bimatoprost—AKR1C3—Disease—LRP5—osteoporosis	0.000586	0.00192	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SOST—osteoporosis	0.000586	0.00192	CbGpPWpGaD
Bimatoprost—Rash—Ethinyl Estradiol—osteoporosis	0.000584	0.000857	CcSEcCtD
Bimatoprost—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000584	0.000856	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—LRP5—osteoporosis	0.000582	0.00191	CbGpPWpGaD
Bimatoprost—Headache—Ethinyl Estradiol—osteoporosis	0.00058	0.000851	CcSEcCtD
Bimatoprost—Rash—Risedronate—osteoporosis	0.00057	0.000835	CcSEcCtD
Bimatoprost—Dermatitis—Risedronate—osteoporosis	0.000569	0.000835	CcSEcCtD
Bimatoprost—Dizziness—Pamidronate—osteoporosis	0.000568	0.000833	CcSEcCtD
Bimatoprost—Headache—Risedronate—osteoporosis	0.000566	0.00083	CcSEcCtD
Bimatoprost—Asthenia—Zoledronate—osteoporosis	0.000563	0.000825	CcSEcCtD
Bimatoprost—AKR1C3—Disease—LRP6—osteoporosis	0.000561	0.00184	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTH1R—osteoporosis	0.000561	0.00184	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CALCR—osteoporosis	0.000561	0.00184	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LRP6—osteoporosis	0.000556	0.00182	CbGpPWpGaD
Bimatoprost—Pruritus—Zoledronate—osteoporosis	0.000555	0.000814	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—PTHLH—osteoporosis	0.000553	0.00181	CbGpPWpGaD
Bimatoprost—Nausea—Ethinyl Estradiol—osteoporosis	0.00055	0.000807	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—PTH—osteoporosis	0.000549	0.0018	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTH1R—osteoporosis	0.000549	0.0018	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CALCR—osteoporosis	0.000549	0.0018	CbGpPWpGaD
Bimatoprost—Insomnia—Estradiol—osteoporosis	0.000547	0.000802	CcSEcCtD
Bimatoprost—Asthenia—Conjugated Estrogens—osteoporosis	0.000542	0.000795	CcSEcCtD
Bimatoprost—Rash—Pamidronate—osteoporosis	0.000541	0.000794	CcSEcCtD
Bimatoprost—Dermatitis—Pamidronate—osteoporosis	0.000541	0.000793	CcSEcCtD
Bimatoprost—Dyspnoea—Estradiol—osteoporosis	0.000539	0.00079	CcSEcCtD
Bimatoprost—AKR1C3—Disease—LTF—osteoporosis	0.000539	0.00177	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—RPL24—osteoporosis	0.000539	0.00177	CbGpPWpGaD
Bimatoprost—Headache—Pamidronate—osteoporosis	0.000538	0.000789	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—PTH—osteoporosis	0.000538	0.00176	CbGpPWpGaD
Bimatoprost—Somnolence—Estradiol—osteoporosis	0.000537	0.000788	CcSEcCtD
Bimatoprost—Nausea—Risedronate—osteoporosis	0.000537	0.000787	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CALCA—osteoporosis	0.000536	0.00176	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CNR2—osteoporosis	0.000535	0.00175	CbGpPWpGaD
Bimatoprost—Pruritus—Conjugated Estrogens—osteoporosis	0.000534	0.000784	CcSEcCtD
Bimatoprost—Dyspepsia—Estradiol—osteoporosis	0.000532	0.00078	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—PTH1R—osteoporosis	0.00053	0.00174	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CALCR—osteoporosis	0.00053	0.00174	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CNR2—osteoporosis	0.000524	0.00172	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Estradiol—osteoporosis	0.000522	0.000765	CcSEcCtD
Bimatoprost—Dizziness—Zoledronate—osteoporosis	0.000519	0.000761	CcSEcCtD
Bimatoprost—Pain—Estradiol—osteoporosis	0.000517	0.000758	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—OXCT1—osteoporosis	0.000516	0.00169	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CA2—osteoporosis	0.000516	0.00169	CbGpPWpGaD
Bimatoprost—Nausea—Pamidronate—osteoporosis	0.00051	0.000748	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—MGLL—osteoporosis	0.000503	0.00165	CbGpPWpGaD
Bimatoprost—Dizziness—Conjugated Estrogens—osteoporosis	0.000499	0.000733	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—PTH—osteoporosis	0.000499	0.00163	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—POMC—osteoporosis	0.000496	0.00163	CbGpPWpGaD
Bimatoprost—Rash—Zoledronate—osteoporosis	0.000495	0.000725	CcSEcCtD
Bimatoprost—Dermatitis—Zoledronate—osteoporosis	0.000494	0.000725	CcSEcCtD
Bimatoprost—Headache—Zoledronate—osteoporosis	0.000491	0.000721	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—PTH—osteoporosis	0.000488	0.0016	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000487	0.0016	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CALCA—osteoporosis	0.000487	0.00159	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CNR2—osteoporosis	0.000486	0.00159	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000477	0.00156	CbGpPWpGaD
Bimatoprost—Rash—Conjugated Estrogens—osteoporosis	0.000476	0.000699	CcSEcCtD
Bimatoprost—Dermatitis—Conjugated Estrogens—osteoporosis	0.000476	0.000698	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CNR2—osteoporosis	0.000476	0.00156	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000474	0.00156	CbGpPWpGaD
Bimatoprost—Headache—Conjugated Estrogens—osteoporosis	0.000473	0.000694	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—TLN1—osteoporosis	0.00047	0.00154	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ACP5—osteoporosis	0.000467	0.00153	CbGpPWpGaD
Bimatoprost—Nausea—Zoledronate—osteoporosis	0.000466	0.000683	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—WNT1—osteoporosis	0.000457	0.0015	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—PTHLH—osteoporosis	0.000455	0.00149	CbGpPWpGaD
Bimatoprost—Nausea—Conjugated Estrogens—osteoporosis	0.000449	0.000658	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—WNT1—osteoporosis	0.000447	0.00147	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MGLL—osteoporosis	0.000446	0.00146	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PTHLH—osteoporosis	0.000445	0.00146	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MGLL—osteoporosis	0.000436	0.00143	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LRP5—osteoporosis	0.000435	0.00143	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TPI1—osteoporosis	0.000434	0.00142	CbGpPWpGaD
Bimatoprost—Asthenia—Estradiol—osteoporosis	0.000434	0.000636	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—IDH2—osteoporosis	0.000428	0.0014	CbGpPWpGaD
Bimatoprost—Pruritus—Estradiol—osteoporosis	0.000428	0.000627	CcSEcCtD
Bimatoprost—PTGER1—Signaling Pathways—LRP5—osteoporosis	0.000426	0.0014	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MGLL—osteoporosis	0.000421	0.00138	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LRP6—osteoporosis	0.000416	0.00136	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—PTHLH—osteoporosis	0.000413	0.00135	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LRP5—osteoporosis	0.000411	0.00135	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—P4HB—osteoporosis	0.000408	0.00134	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LRP6—osteoporosis	0.000407	0.00133	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—P4HB—osteoporosis	0.000405	0.00133	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—PTHLH—osteoporosis	0.000405	0.00133	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP27A1—osteoporosis	0.000402	0.00132	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—GAPDH—osteoporosis	0.000401	0.00131	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CALCA—osteoporosis	0.000401	0.00131	CbGpPWpGaD
Bimatoprost—Dizziness—Estradiol—osteoporosis	0.0004	0.000586	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—PTH—osteoporosis	0.000394	0.00129	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LRP6—osteoporosis	0.000393	0.00129	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CALCA—osteoporosis	0.000392	0.00129	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ACP5—osteoporosis	0.000391	0.00128	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—RAP1A—osteoporosis	0.000387	0.00127	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000386	0.00127	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CNR2—osteoporosis	0.000384	0.00126	CbGpPWpGaD
Bimatoprost—Rash—Estradiol—osteoporosis	0.000381	0.000559	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—ADCY5—osteoporosis	0.000381	0.00125	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NFATC1—osteoporosis	0.000381	0.00125	CbGpPWpGaD
Bimatoprost—Dermatitis—Estradiol—osteoporosis	0.000381	0.000559	CcSEcCtD
Bimatoprost—Headache—Estradiol—osteoporosis	0.000379	0.000555	CcSEcCtD
Bimatoprost—AKR1C3—Disease—DKK1—osteoporosis	0.000378	0.00124	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NFATC1—osteoporosis	0.000378	0.00124	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—DKK1—osteoporosis	0.000375	0.00123	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—POMC—osteoporosis	0.000371	0.00122	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—WNT1—osteoporosis	0.000364	0.00119	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CALCA—osteoporosis	0.000364	0.00119	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—TPI1—osteoporosis	0.000364	0.00119	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—POMC—osteoporosis	0.000363	0.00119	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—WNT1—osteoporosis	0.000361	0.00118	CbGpPWpGaD
Bimatoprost—Nausea—Estradiol—osteoporosis	0.000359	0.000527	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—CALCA—osteoporosis	0.000356	0.00117	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—FGA—osteoporosis	0.000354	0.00116	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TLN1—osteoporosis	0.000351	0.00115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGA—osteoporosis	0.000351	0.00115	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—ADCY5—osteoporosis	0.000346	0.00113	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TLN1—osteoporosis	0.000344	0.00113	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—P4HB—osteoporosis	0.000342	0.00112	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GAPDH—osteoporosis	0.000336	0.0011	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TLN1—osteoporosis	0.000332	0.00109	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—RAP1A—osteoporosis	0.000327	0.00107	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PTHLH—osteoporosis	0.000326	0.00107	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—BMP2—osteoporosis	0.000326	0.00107	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—FGB—osteoporosis	0.000319	0.00105	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ENO1—osteoporosis	0.000316	0.00103	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PSMA2—osteoporosis	0.000311	0.00102	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—PSMA5—osteoporosis	0.000311	0.00102	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PSMA2—osteoporosis	0.000308	0.00101	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PSMA5—osteoporosis	0.000308	0.00101	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—P4HB—osteoporosis	0.000303	0.000993	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—P4HB—osteoporosis	0.000296	0.000972	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTH—osteoporosis	0.000295	0.000966	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—CALCA—osteoporosis	0.00029	0.00095	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAP1A—osteoporosis	0.00029	0.000949	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTH—osteoporosis	0.000288	0.000945	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CALCA—osteoporosis	0.000287	0.000942	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CNR2—osteoporosis	0.000287	0.000941	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—P4HB—osteoporosis	0.000286	0.000938	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000286	0.000937	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000285	0.000935	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADCY5—osteoporosis	0.000285	0.000934	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAP1A—osteoporosis	0.000283	0.000929	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NFATC1—osteoporosis	0.000282	0.000926	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CNR2—osteoporosis	0.000281	0.000921	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—POMC—osteoporosis	0.00028	0.000919	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—DKK1—osteoporosis	0.00028	0.000919	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.00028	0.000917	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADCY5—osteoporosis	0.000279	0.000914	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTH—osteoporosis	0.000278	0.000912	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NFATC1—osteoporosis	0.000276	0.000906	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—DKK1—osteoporosis	0.000274	0.000899	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAP1A—osteoporosis	0.000273	0.000896	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CNR2—osteoporosis	0.000271	0.000889	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—WNT1—osteoporosis	0.00027	0.000885	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NFATC1—osteoporosis	0.000267	0.000874	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—DKK1—osteoporosis	0.000265	0.000867	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ENO1—osteoporosis	0.000264	0.000866	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—WNT1—osteoporosis	0.000264	0.000866	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KL—osteoporosis	0.000263	0.000863	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGA—osteoporosis	0.000263	0.000861	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—KL—osteoporosis	0.000261	0.000856	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PSMA5—osteoporosis	0.00026	0.000854	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—PSMA2—osteoporosis	0.00026	0.000854	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADCY5—osteoporosis	0.000259	0.000848	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGA—osteoporosis	0.000257	0.000843	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—WNT1—osteoporosis	0.000255	0.000836	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—POMC—osteoporosis	0.000255	0.000834	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—ADCY5—osteoporosis	0.000253	0.00083	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6R—osteoporosis	0.000248	0.000814	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGA—osteoporosis	0.000248	0.000813	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PTHLH—osteoporosis	0.000244	0.0008	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—BMP2—osteoporosis	0.000244	0.0008	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PTHLH—osteoporosis	0.000239	0.000783	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—BMP2—osteoporosis	0.000239	0.000783	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—FGB—osteoporosis	0.000239	0.000783	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FGB—osteoporosis	0.000234	0.000767	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PSMA5—osteoporosis	0.000231	0.000756	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—PSMA2—osteoporosis	0.000231	0.000756	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PTHLH—osteoporosis	0.000231	0.000756	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—BMP2—osteoporosis	0.000231	0.000756	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PSMA2—osteoporosis	0.000226	0.00074	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PSMA5—osteoporosis	0.000226	0.00074	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—FGB—osteoporosis	0.000226	0.00074	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PSMA2—osteoporosis	0.000218	0.000714	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—PSMA5—osteoporosis	0.000218	0.000714	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CALCA—osteoporosis	0.000215	0.000705	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP19A1—osteoporosis	0.000211	0.000693	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CALCA—osteoporosis	0.00021	0.00069	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—POMC—osteoporosis	0.00021	0.000687	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ADCY5—osteoporosis	0.000206	0.000676	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—POMC—osteoporosis	0.000205	0.000673	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ADCY5—osteoporosis	0.000204	0.00067	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CALCA—osteoporosis	0.000203	0.000665	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SPP1—osteoporosis	0.000198	0.000648	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KL—osteoporosis	0.000195	0.00064	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KL—osteoporosis	0.000191	0.000626	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—POMC—osteoporosis	0.00019	0.000624	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MTHFR—osteoporosis	0.00019	0.000622	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—POMC—osteoporosis	0.000186	0.000611	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6R—osteoporosis	0.000186	0.000609	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KL—osteoporosis	0.000184	0.000604	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6R—osteoporosis	0.000182	0.000596	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS2—osteoporosis	0.00018	0.000591	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS2—osteoporosis	0.000179	0.000586	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LEP—osteoporosis	0.000175	0.000574	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ADCY5—osteoporosis	0.000173	0.000566	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GPX1—osteoporosis	0.000172	0.000564	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ESR1—osteoporosis	0.000167	0.000548	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—MTHFR—osteoporosis	0.000159	0.000521	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IRS1—osteoporosis	0.000157	0.000516	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IRS1—osteoporosis	0.000156	0.000512	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADCY5—osteoporosis	0.000153	0.000501	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—POMC—osteoporosis	0.00015	0.000493	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADCY5—osteoporosis	0.00015	0.000491	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6R—osteoporosis	0.000148	0.000485	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SPP1—osteoporosis	0.000148	0.000485	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6R—osteoporosis	0.000147	0.000481	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SPP1—osteoporosis	0.000145	0.000475	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IGF1—osteoporosis	0.000145	0.000474	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADCY5—osteoporosis	0.000144	0.000473	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SPP1—osteoporosis	0.00014	0.000458	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS2—osteoporosis	0.000134	0.000438	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS2—osteoporosis	0.000131	0.000429	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—osteoporosis	0.000131	0.000429	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—osteoporosis	0.000128	0.00042	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—POMC—osteoporosis	0.000127	0.000416	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS2—osteoporosis	0.000126	0.000414	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ESR1—osteoporosis	0.000125	0.00041	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—osteoporosis	0.000124	0.000405	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ESR1—osteoporosis	0.000122	0.000401	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ESR1—osteoporosis	0.000118	0.000387	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IRS1—osteoporosis	0.000117	0.000383	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IRS1—osteoporosis	0.000114	0.000375	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—POMC—osteoporosis	0.000112	0.000369	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—osteoporosis	0.000111	0.000363	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IRS1—osteoporosis	0.00011	0.000361	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—POMC—osteoporosis	0.00011	0.000361	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6R—osteoporosis	0.00011	0.00036	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IGF1—osteoporosis	0.000108	0.000355	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6R—osteoporosis	0.000107	0.000352	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—POMC—osteoporosis	0.000106	0.000348	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IGF1—osteoporosis	0.000106	0.000347	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6R—osteoporosis	0.000104	0.00034	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IGF1—osteoporosis	0.000102	0.000335	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—MYC—osteoporosis	8.77e-05	0.000287	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—osteoporosis	8.74e-05	0.000287	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MYC—osteoporosis	8.69e-05	0.000285	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—osteoporosis	8.67e-05	0.000284	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—osteoporosis	8.27e-05	0.000271	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—osteoporosis	8.1e-05	0.000265	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—osteoporosis	6.59e-05	0.000216	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—osteoporosis	6.53e-05	0.000214	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MYC—osteoporosis	6.5e-05	0.000213	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—osteoporosis	6.48e-05	0.000213	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MYC—osteoporosis	6.36e-05	0.000209	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—osteoporosis	6.35e-05	0.000208	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MYC—osteoporosis	6.14e-05	0.000201	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—osteoporosis	6.12e-05	0.000201	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—osteoporosis	4.89e-05	0.00016	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—osteoporosis	4.78e-05	0.000157	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—osteoporosis	4.61e-05	0.000151	CbGpPWpGaD
